📰 Two Phase News
Page 5 - Two Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Two Phase. Real-time updates on events, politics, business and more.
September 19, 2022
Investegate announcements from GNT Pharma Co., Ltd, GNT Pharma Provides Update on Two Phase III Studies of Nelonemdaz for Acute Ischemic Stroke Patients Treated with tPA (ENIS-3) or Endovascular Thrombectomy (RODIN)
August 24, 2022
Incyte (Nasdaq:INCY) today announced that multiple abstracts featuring data from its dermatology portfolio will be presented at the upcoming 2022 European Academy of Dermatology and Venereology (EADV)
July 10, 2022
Fitusiran prophylaxis reduced bleeds by 61% in people with hemophilia A or B, with or without inhibitors, compared to prior factor or bypassing agent prophylaxis A median annualized bleeding rate
June 22, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
June 21, 2022
Potential for paradigm shift in CAR-T therapy with CellPoint's decentralized point-of-care manufacturing model, in partnership with Lonza, and AboundBio's cutting-edge fully human antibody-based
June 21, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
June 21, 2022
Potential for paradigm shift in CAR-T therapy with CellPoint’s decentralized point-of-care manufacturing model, in partnership with Lonza, and AboundBio’s...
June 21, 2022
Investegate announcements from Galapagos NV, Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies
May 25, 2022
-Data featured in two oral presentations at the 8th Society of Endometriosis and Uterine Disorders Congress and a poster presentation at the International Society of Gynecological Endocrinology 20th
May 25, 2022
Investegate announcements from ObsEva SA, ObsEva Presents Clinical Data on Oral GnRH Antagonist Linzagolix at Multiple Congresses